|
David Krause, M.D., FACP, joined Zelos as Senior Vice President, Head of R&D and Chief Medical Officer in 2008. From 2006 through 2008 Dr. Krause was a Principal with Delta Pharmaceutical Consulting LLC, a private consulting firm to the pharmaceutical industry. Dr. Krause has extensive experience in the biopharmaceutical space. He served as Chief Medical Officer of Vicuron (subsequently acquired by Pfizer) from 2002 to 2005 and held various drug development and medical affairs leadership positions in multiple relevant clinical groups, including Biologicals, Inflammation and Tissue Repair and Pulmonary and Diabetes, at SmithKline Beecham and GlaxoSmithKline. During his tenure at these companies, Dr. Krause led the successful development and FDA approval of a number of important products in these therapeutic areas. The author of more than 40 scientific publications and abstracts, Dr. Krause has served as a consultant to the Department of Defense on infectious disease and vaccine-related issues. He received his M.D. from Temple University School of Medicine and trained in internal medicine at the Medical College of Pennsylvania and Temple University Hospital. | 